Alvotech (NASDAQ:ALVOW – Get Free Report) saw a large decrease in short interest during the month of May. As of May 15th, there was short interest totaling 601 shares, a decrease of 41.8% from the April 30th total of 1,032 shares. Based on an average daily trading volume, of 4,491 shares, the days-to-cover ratio is currently 0.1 days.
Alvotech Stock Performance
Shares of Alvotech stock opened at $0.24 on Tuesday. Alvotech has a one year low of $0.12 and a one year high of $3.00. The firm has a fifty day moving average of $0.25 and a two-hundred day moving average of $0.45.
Alvotech Company Profile
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Further Reading
- Five stocks we like better than Alvotech
- Will the SpaceX IPO Put These 5 Public Space Stocks Into a Higher Orbit?
- Palantir’s Drone Tailwind Puts Its Defense AI Story Back in Focus for Investors
- Why 1 Little-Known ETF Is Riding the AI Chip Shortage
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
